Anti-Human CGRP Recombinant Antibody(Fremanezumab)
-
Product Number
YR1426
-
Alias
科研级 Fremanezumab ( 瑞玛奈珠单抗 ), Anti-CGRP Recombinant Antibody, Research Grade Fremanezumab
-
Specifications
- 1mg
- 5mg
YR1426
科研级 Fremanezumab ( 瑞玛奈珠单抗 ), Anti-CGRP Recombinant Antibody, Research Grade Fremanezumab
| Alias | 科研级 Fremanezumab ( 瑞玛奈珠单抗 ), Anti-CGRP Recombinant Antibody, Research Grade Fremanezumab |
| Catalog Number | YR1426 |
| Molecular Name | Fremanezumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG2 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Fremanezumab, sold under the brand name Ajovy, is a medication used to prevent migraines in adults. It is given by injection under the skin. The most common side effect is pain and redness at the site of injection. Other side effects include allergic reactions. It is in the calcitonin gene-related peptide antagonist class of medications. |
| CAS Number | 1655501-53-3 |
| Application | ELISA, IHC, FCM, IP, IF, Inhib, FuncS |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CGRP[Homo sapiens] |
0